In another study by Wei et al. [19] which investigated the association of PD-1 upregulation with disease progression, it was reported that PD-1+ CD4+ and PD-1+ CD8+ TILs were significantly increased in grade III and IV gliomas. This evidence concerns the gene CD4 and central nervous system cancer.